The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging.

Ann-Christin EderMohamed A OmraneSven StadlbauerMareike RoscherWael Y KhoderChristian GratzkeKlaus KopkaMatthias EderPhilipp T MeyerCordula A JilgJuri Ruf

Published in: European journal of nuclear medicine and molecular imaging (2021)

Keyphrases

pet ct
fluorescence imaging
prostate cancer
photodynamic therapy
patients undergoing
radical prostatectomy
positron emission tomography
computed tomography